These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical aspects of dextran. Matheson NA Acta Anaesthesiol Belg; 1968; 19(2):157-78. PubMed ID: 5746326 [No Abstract] [Full Text] [Related]
3. The effect of infused albumin and Rheomacrodex on factors governing the flow properties of the human blood. Groth CG Acta Chir Scand; 1966 Apr; 131(4):290-7. PubMed ID: 5927254 [No Abstract] [Full Text] [Related]
4. [Changes in the blood coagulation system in acute hypoxia in rabbits and various methods of their correction]. Bakanskaia VV Fiziol Zh (1978); 1986; 32(2):217-21. PubMed ID: 2423380 [No Abstract] [Full Text] [Related]
5. [On blood coagulation following osmo-oncotherapy]. Schmidt K; Reese L; Wolf P Anaesthesist; 1968 Jan; 17(1):13-7. PubMed ID: 5669457 [No Abstract] [Full Text] [Related]
6. Dextran infusions and extracellular volume. Rothschild MA; Oratz M; Schreiber SS; Evans CD J Nucl Med; 1965 Nov; 6(11):838-43. PubMed ID: 5846785 [No Abstract] [Full Text] [Related]
9. [Trial prevention of thrombosis with low molecular weight dextran during selective arteriography]. Heitz F; Sotty M; Grellet J; Hubin F; Roucayrol R Ann Radiol (Paris); 1971; 14(5):501-10. PubMed ID: 5562778 [No Abstract] [Full Text] [Related]
10. [Physiologic principles of coagulation thrombosis prophylaxis]. Schmutzler R Med Welt; 1981 Jul; 32(30-31):1164-6. PubMed ID: 7278583 [No Abstract] [Full Text] [Related]
11. [Antithrombotic effect of acetylsalicylic acid, heparin and phenprocoumon on the formation of experimental coagulation thrombi]. Zimmermann R; Barth P; Masche R Verh Dtsch Ges Inn Med; 1974; 80():1446-8. PubMed ID: 4454451 [No Abstract] [Full Text] [Related]
12. [Effect of contrast media on blood coagulation system]. Sviridov NK Vestn Khir Im I I Grek; 1975 Mar; 114(3):133-4. PubMed ID: 1119023 [No Abstract] [Full Text] [Related]
13. Drugs five years later: dextran 40. Data JL; Nies AS Ann Intern Med; 1974 Oct; 81(4):500-4. PubMed ID: 4606455 [No Abstract] [Full Text] [Related]
14. Recent advances in the prophylaxis of venous thromboembolism: modulating the coagulation cascade. Introduction. Hawkins DW Am J Health Syst Pharm; 2001 Nov; 58 Suppl 2():S2-3. PubMed ID: 11715836 [No Abstract] [Full Text] [Related]
15. Prolonged fibrinolytic prophylactic treatment with nicotinic acid derivatives and MAO-inhibitors. De Nicola P Thromb Diath Haemorrh Suppl; 1966; 20():289-95. PubMed ID: 5298378 [No Abstract] [Full Text] [Related]
16. Objective measurement of the dispersing effect of dextran 40 on red cells from man, dog, and rabbit. Engeset J; Stalker AL; Matheson NA Cardiovasc Res; 1967 Oct; 1(4):385-8. PubMed ID: 6066343 [No Abstract] [Full Text] [Related]
17. [Principles of prophylaxis of thrombosis and thromboembolism in oncosurgery]. Pashanov ED; Rumiantsev AG Klin Khir; 2007 Sep; (9):44-8. PubMed ID: 18318058 [No Abstract] [Full Text] [Related]
18. Some effects of low molecular weight dextran on coagulation. Dugdale M; Nofzinger JD; Murphey F Thromb Diath Haemorrh; 1966 Jan; 15(1):118-30. PubMed ID: 5919795 [No Abstract] [Full Text] [Related]
19. [Physico-chemical and quantitative studies of electrophoresis]. Ulashchik VS Vopr Kurortol Fizioter Lech Fiz Kult; 1974; (5):296-401. PubMed ID: 4446421 [No Abstract] [Full Text] [Related]
20. [Prophylaxis of thromboembolism using low dosage heparin (author's transl)]. Frick U; Frick G Zentralbl Chir; 1979; 104(1):1-9. PubMed ID: 369234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]